Annual report
Page 1
Table of Contents ( Mark One ) ☐ ☑ ☐ ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 20 - F REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES ACT OF 1934 OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from OR to SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report . Commission file number : 001-39316 Burning Rock Biotech Limited ( Exact name of Registrant as specified in its charter ) N / A ( Translation of Registrant's name into English ) Cayman Islands ( Jurisdiction of incorporation or organization ) 601 , 6 / F , Building 3 , Standard Industrial Unit 2 No. 7 , Luoxuan 4th Road , International Bio Island , Guangzhou , 510005 The People's Republic of China ( Address of principal executive offices ) Mr. Leo Li , Chief Financial Officer Telephone : +86 020-3403 7871 Email : leo.li@brbiotech.com 601 , 6 / F , Building 3 , Standard Industrial Unit 2 No. 7 , Luoxuan 4th Road , International Bio Island , Guangzhou , 510005 The People's Republic of China ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Securities registered or to be registered , pursuant to Section 12 ( b ) of the Act . Trading Symbol BNR Title of each class American depositary shares , each representing one Class A ordinary share Class A ordinary share , par value US $ 0.0002 per * share * Name of each exchange on which registered The Nasdaq Stock Market LLC ( The Nasdaq Global Market ) The Nasdaq Stock Market LLC ( The Nasdaq Global Market ) Not for trading , but only in connection with the listing of the Nasdaq Global Market of American depositary shares . Securities registered or to be registered pursuant to Section 12 ( g ) of the Act . None ( Title of Class ) Securities for which there is a reporting obligation pursuant to Section 15 ( d ) of the Act . None ( Title of Class )